Jennifer Kahn
PER
Jennifer Kahn Kahn
Jennifer Kahn writes in Wired, the problem is, in the United States, the number of patients who are willing to sign up for clinical trials is abysmally low. Ms. Kahn writes that as many as half of all clinical trials are already conducted in countries like India, China and Brazil, adding that countries are now jockeying to attract trial drugs, both because the medications may prove to be helpful and to receive the money the research companies spend on the tests.